Related Experiment Video
Updated: Jul 20, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy
D M Bonifati1, S F Witchel, M Ermani
1Department of Neurosciences, University of Padova, via Giustiniani 5, 35128 Padova, Italy.
Background:
Steroid administration is beneficial in Duchenne muscular dystrophy (DMD), but the response, incidence, and the severity of side effects are variable.
Aims:
To investigate whether glucocorticoid receptor (GRL) gene polymorphisms may be responsible for glucocorticoid sensitivity in DMD.
Methods:
Forty eight DMD patients treated either with prednisone or deflazacort were subjected to genetic analyses of the GRL gene.
Results:
Mutation studies revealed an heterozygous A to G mutation at GRL cDNA position 1220 in three DMD patients resulting in an asparagine to serine amino acid change at amino acid position 363 (N363S). The N363S carrier DMD patients showed a trend towards a later age at loss of ambulation in comparison with non-carrier patients.
Conclusions:
These data suggest that the N363S GRL polymorphism may be implicated in the long term response to glucocorticoids.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Satellite Stem Cells and Muscular Dystrophy
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

